Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Donald R. McLachlan"'
Autor:
Maire E. Percy, Vivian Jaber, Nathan M. Sharfman, Yuhai Zhao, T.P.A. Kruck, Wenhong Li, Donald R. McLachlan, Walter J. Lukiw, William J. Walsh, Aileen I. Pogue, Zhide Fang, Catherine Bergeron, Peter N. Alexandrov
Publikováno v:
Molecular Neurobiology. 56:1531-1538
With continuing cooperation from 18 domestic and international brain banks over the last 36 years, we have analyzed the aluminum content of the temporal lobe neocortex of 511 high-quality human female brain samples from 16 diverse neurological and ne
Autor:
Nathan M. Sharfman, Walter J. Lukiw, Zhide Fang, Maire E. Percy, Catherine Bergeron, Yuhai Zhao, Peter N. Alexandrov, William J. Walsh, Aileen I. Pogue, Wenhong Li, Frank Culicchia, T.P.A. Kruck, Donald R. McLachlan, Vivian Jaber
Publikováno v:
Journal of Alzheimer's disease & Parkinsonism
Aluminum is a ubiquitous neurotoxin highly enriched in our biosphere, and has been implicated in the etiology and pathology of multiple neurological diseases that involve inflammatory neural degeneration, behavioral impairment and cognitive decline.
Publikováno v:
Electrophoresis. 21:2359-2367
Existing methods for the analysis of histone H1 by capillary electrophoresis (CE) employ acidic buffers (pH
Publikováno v:
Journal of Molecular Neuroscience. 11:67-78
The incorporation of [alpha-32P]-uridine triphosphate into DNA transcription products was examined in short post-mortem interval (PMI) human brain neocortical nuclei (n, 22; PMI, 0.5-24 h) using run-on-gene transcription. Reverse Northern dot-blot hy
Publikováno v:
Therapeutic Drug Monitoring. 15:602-607
Drug trials designed to modify the progression of Alzheimer's disease (AD) have required the development of mental state and behavior evaluation instruments that are sensitive to cognitive decline and measure skills useful in everyday living. We desc
Publikováno v:
Clinical Biochemistry. 26:339-349
One of the principal identifying features of Alzheimer's disease (AD) is the extracellular deposition of fibrous protein aggregates in the form of amyloid plaques. The major component of these deposits is the amyloid beta (A beta) protein that is a p
Autor:
Donald R. McLachlan, Sharon J. Bauer, Martin J. Somerville, Barbara Chodakowski, Ethylin Wang Jabs, Dorothy A. Miller, Maire E. Percy, Thomas G. Dearie, Anne Lennox, Antonio Baldini
Publikováno v:
American Journal of Medical Genetics. 47:14-19
We have further characterized an unusual 22p+ marker chromosome with a double nucleolus organizer region (dNOR) previously identified in a family with late-onset dementia of the Alzheimer type. G-banding and morphology of the marker's q arm were typi
Publikováno v:
Journal of Neurochemistry. 61:298-305
The serine protease inhibitor α1-antichymotrypsin (ACT) consistently colocalizes with amyloid deposits of Alzheimer's disease (AD) and may contribute to the generation of amyloid proteins and/or physically affect fibril assembly. AD amyloid fibrils
Autor:
A.J. Dalton, Ann C. M. Rusk, Martin J. Somerville, Barbara Chodakowski, Joseph M. Berg, Donald R. McLachlan, David F. Andrews, Vjerica D. Markovic, Maire E. Percy
Publikováno v:
American Journal of Medical Genetics. 45:584-588
We previously observed low level mosaicism (2–4% normal cells) in phytohemagglutinin-stimulated peripheral blood lymphocytes (PBL) in 29% of a small group of elderly persons with Down syndrome (DS). An analysis of cytogenetic data on 154 trisomy 21
A predictor for side effects in patients with Alzheimer's disease treated with deferoxamine mesylate
Publikováno v:
Clinical Pharmacology and Therapeutics. 53:30-37
In a previously reported clinical trial, patients with Alzheimer's disease were treated with deferoxamine mesylate, which resulted in a 50% reduction in the average rate of deterioration over 2 years. There were five deaths in the untreated group dur